Concurrent Investment Advisors »

Beam Therapeutics shares owned by Concurrent Investment Advisors

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Concurrent Investment Advisors from 13F filings

Historical chart of Concurrent Investment Advisors investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Concurrent Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Concurrent Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-03-31 $371k 19k 19.53

More positions owned by Concurrent Investment Advisors

Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation Put Option (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Total Stk Mkt (VTI)
Pimco Etf Tr Active Bd Etf (BOND)
Broadcom (AVGO)
Spdr Gold Tr Gold Shs (GLD)

View all positions for Concurrent Investment Advisors

Top funds holding Beam Therapeutics

FMR
ARK Investment Management
Farallon Capital Management
Vanguard Group
BlackRock
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Arch Venture Corp
State Street Corporation
Bellevue Group
Kynam Capital Management
Geode Capital Management
MWG Management
Dimensional Fund Advisors
Ubs Global Asset Management Americas

View all funds holding Beam Therapeutics